Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

CUPR - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$4.96M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Cuprina Holdings (Cayman) Limited Class A Ordinary SharesCuprina Holdings (Cayman) Limited Class A Ordinary Shares-1.2---0.1
$0.04

Current Fair Value

98% downside

Overvalued by 98% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$4.96 Million
Enterprise Value$2.33 Million
Earnings per Share$-1.84
Beta-0.38
Outstanding Shares2,681,250

Return

Return on EquityNaN%ROE
Return on AssetsNaN%
Return on Invested CapitalNaN%

Valuation & Multiples

P/E Ratio-1.24P/E Ratio
PEG-PEG
Price to Sales-Price to Sales
Price to Book Ratio1.86Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income-
Total Debt to Enterprise0.21
Debt to Equity0.1Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
July 27, 2026
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.43%▲ 0.21%
Total Invested$25,879▲ 36.86%
Investors Holding4▲ 1.00%

About Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

10 employees
CEO: Yong Qi Quek

Cuprina Holdings (Cayman) Limited is a Singaporean biotechnology and biomedical enterprise, primarily dedicated to pioneering and bringing to market advanced solutions for the management of persistent wounds. The company produces and sup...